MKMatthew W. Kemp

Matthew W. Kemp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew W. Kemp has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning–Based First-Trimester Antenatal Risk Prediction for Adverse Maternal and Neonatal Outcomes: Multicenter Model Development Study

    by Sarah Li, David Y Y Tan, Jingxian Zhang, Aniza P Mahyuddin, Harshaana Ramlal, Sebastian E Illanes, Max Monckeberg, Alejandra F Plaza, Maria L Paz Morgan, Matthew W Kemp, et al.

    Background: Maternal outcomes remain inequitable worldwide. Severe morbidity persists, and current risk assessment tools are largely arbitrary, focusing on biomedical factors while overlooking social determinants of health. There is a need for data-driven AI models to improve early pregnancy risk identification and management. Objective: The study aimed to develop and internally validate first-trimester AI-based antenatal risk assessment models across three geographically and socioethnically diverse populations (Sweden, Chile, and Singapore) and to compare their performance with existing clinical risk assessment strategies. Methods: We conducted a retrospective population-based study using routinely collected first-trimester data from over 700,000 pregnancies from Sweden, Chile, and Singapore. Separate machine learning models predicting a composite of adverse maternal and neonatal outcomes were trained and internally validated for each population. Input variables were limited to information available at or before 14 weeks’ gestation. Model discrimination, measured by the area under the receiver operating characteristic (AUROC) curve, was compared with corresponding proxies for real-world first-trimester risk assessment approaches in each setting. Model interpretability was assessed using Shapley additive explanations. Results: The prevalence of the composite adverse outcome was 10.40% (75,647/727,354) in Sweden, 21.94% (1302/5934) in Chile, and 16.25% (6145/37,813) in Singapore. In Sweden, the guideline-based risk assessment achieved an AUROC of 0.53, compared with 0.65 for the LightGBM (light gradient boosting machine) model ( P <.001). In Chile, the midwifery-led risk assessment achieved an AUROC of 0.52, versus 0.65 from the traditional machine learning LightGBM model ( P <.001). In Singapore, the health care professional–based risk assessment reached an AUROC of 0.56, compared with 0.60 for the LightGBM model ( P <.05). In the Swedish and Singapore cohorts, sociodemographic variables were among the most influential predictive features. At a false-positive rate of 50.0%, the sensitivities for predicting the primary composite adverse outcome were 69.17%, 69.62%, and 64.93% for the Sweden, Chile, and Singapore models, respectively. At a 30.0% false-positive rate operating point, the sensitivities were lower, at 50.38%, 55.38%, and 44.75%, respectively, but with higher positive predictive values of 16.31%, 34.53%, and 22.32%, respectively. The model calibration plots showed reasonable agreement in Sweden and Singapore, whereas the Chile model showed poorer calibration, with a calibration slope of approximately 1.45, indicating underconfidence. Conclusions: AI-based models developed using first-trimester data generally demonstrated improved performance compared with existing first-trimester clinical risk stratification strategies across three distinct populations. These findings suggest the potential feasibility of population-specific, AI-enabled risk stratification as a clinical decision support tool and highlight the potential value of integrating social, demographic, and behavioral determinants into antenatal risk assessment frameworks to support more equitable and personalized antenatal care.

  • Interleukin-1 Receptor Antagonists Partially Inhibited Histological Injury but Not Tissue Inflammation in a Sheep Model of Pregnancy

    by Yuki Takahashi, Erin L. Fee, Tsukasa Takahashi, Haruo Usuda, Hideyuki Ikeda, Sean W. Carter, Yuya Saito, Shinichi Sato, Noriyoshi Mochii, Sylvain Chemtob, et al.

    Intrauterine inflammation is a significant cause of early preterm birth and fetal injury. There is a lack of effective interventions for intrauterine inflammation. This study aimed to determine whether direct fetal treatment with IL-1 receptor antagonists (IL-1RA), specifically anakinra (competitive IL-1RA) or rytvela (allosteric IL-1RA), could reduce intrauterine inflammation caused by intraamniotic injection of E. coli lipopolysaccharides (LPS) in a sheep model of pregnancy. We hypothesized the fetal intramuscular administration of IL1-RA therapy would comprehensively resolve intrauterine inflammation caused by LPS in the pregnant sheep model. Date-mated Merino ewes carrying single fetuses were randomized into four groups: LPS Group (10 mg intraamniotic LPS injection followed by saline), RYTVELA Group (10 mg LPS injection followed by 5 mg rytvela), ANAKINRA Group (LPS injection followed by 100 mg anakinra), and SALINE Group (saline injection followed by saline). All LPS-exposed fetuses had elevated bilirubin levels, leukopenia, and increased inflammatory mediators IL-1β, IL-8, tumour necrosis factor alpha (TNFα), and monocyte chemoattractant protein 1 (MCP-1) in amniotic fluid and lung tissue. Both anakinra and rytvela treatments reduced immunocyte infiltration in chorioamniotic membranes and lungs, and microglial staining, and increased the oligodendrocyte staining, but did not significantly resolve overall inflammation compared to the SALINE Group. In conclusion, fetal intramuscular administration of anakinra and rytvela did not effectively resolve intrauterine inflammation but showed potential in reducing tissue invasion and brain injury markers. These findings suggest that modest inflammation reduction may protect against brain injury and preterm birth, though no additional benefit was observed compared to intraamniotic IL-1RA treatment.


  • Open Access

    Upregulation of hepatic nuclear receptors in extremely preterm ovine fetuses undergoing artificial placenta therapy

    by Hideyuki Ikeda, Shimpei Watanabe, Shinichi Sato, Erin L. Fee, Sean W. D. Carter, Yusaku Kumagai, Tsukasa Takahashi, Shinichi Kawamura, Takushi Hanita, Sebastian E. Illanes, et al.

    Extremely preterm infants have low Nuclear Receptor (NR) expression in their developing hepatobiliary systems, as they rely on the placenta and maternal liver for compensation. NRs play a crucial role in detoxification and the elimination of both endogenous and xenobiotic substances by regulating key genes encoding specific proteins. In this study, we utilized an Artificial Placenta Therapy (APT) platform to examine the liver tissue expression of NRs of extremely preterm ovine fetuses. This fetal model, resembling a "knockout placenta," lacks placental and maternal support, while maintaining a healthy extrauterine survival. Six ovine fetuses at 95 ± 1 d gestational age (GA; term = ∼150 d)/∼600 g delivery weight were maintained on an APT platform for a period of 120 h (APT Group). Six age-matched, in utero control fetuses were delivered at 99-100 d GA (Control Group). Fetal liver tissue samples and blood samples were collected at delivery from both groups and assessed mRNA expression of NRs and target transporters involved in the hepatobiliary transport system using quantitative PCR. Data were tested for group differences with ANOVA (p < .05 deemed significant). mRNA expression of NRs was identified in both the placenta and the extremely preterm ovine fetal liver. The expression of HNF4α, LRH1, LXR, ESR1, PXR, CAR, and PPARα/γ were significantly elevated in the liver of the APT Group compared to the Control Group. Moreover, target transporters NTCP, OATP1B3, BSEP, and MRP4 were upregulated, whereas MRP2 and MRP3 were unchanged. Although there was no evidence of liver necrosis or apoptotic changes histologically, there was an impact in the fetal liver of the ATP group at the tissue level with a significant increase in TNFα mRNA, a cytokine involved in liver inflammation, and blood elevation of transaminases. A number of NRs in the fetal liver were significantly upregulated after loss of placental-maternal support. However, the expression of target transporter genes appeared to be insufficient to compensate role of the placenta and maternal liver and avoid fetal liver damage, potentially due to insufficient excretion of organic anions.


  • LPCAT1 levels in the placenta, the maternal plasma and the fetal plasma do not predict fetal lung responses to glucocorticoids in a sheep model of pregnancy

    by Tsukasa Takahashi, Erin L. Fee, Yuki Takahashi, Haruo Usuda, Sean W.D. Carter, Hideyuki Ikeda, Masatoshi Saito, Yusaku Kumagai, James P. Bridges, Alan H. Jobe, et al.

  • Open Access

    Direct administration of the non-competitive interleukin-1 receptor antagonist rytvela transiently reduced intrauterine inflammation in an extremely preterm sheep model of chorioamnionitis

    by Yuki Takahashi, Masatoshi Saito, Haruo Usuda, Tsukasa Takahashi, Shimpei Watanabe, Takushi Hanita, Shinichi Sato, Yusaku Kumagai, Shota Koshinami, Hideyuki Ikeda, et al.

    Background: Intraamniotic inflammation is associated with up to 40% of preterm births, most notably in deliveries occurring prior to 32 weeks’ gestation. Despite this, there are few treatment options allowing the prevention of preterm birth and associated fetal injury. Recent studies have shown that the small, non-competitive allosteric interleukin (IL)-1 receptor inhibitor, rytvela, may be of use in resolving inflammation associated with preterm birth (PTB) and fetal injury. We aimed to use an extremely preterm sheep model of chorioamnionitis to investigate the anti-inflammatory efficacy of rytvela in response to established intra-amniotic (IA) lipopolysaccharide (LPS) exposure. We hypothesized that rytvela would reduce LPS-induced IA inflammation in amniotic fluid (AF) and fetal tissues. Methods: Sheep with a single fetus at 95 days gestation (estimated fetal weight 1.0 kg) had surgery to place fetal jugular and IA catheters. Animals were recovered for 48 hours before being randomized to either: i) IA administration of 2 ml saline 24 hours before 2 ml IA and 2 ml fetal intravenous (IV) administration of saline (Saline Group, n = 7); ii) IA administration of 10 mg LPS in 2 ml saline 24 hours before 2 ml IA and 2 ml fetal IV saline (LPS Group, n = 10); 3) IA administration of 10 mg LPS in 2 ml saline 24 hours before 0.3 mg/fetal kg IA and 1 mg/fetal kg fetal IV rytvela in 2 ml saline, respectively (LPS + rytvela Group, n = 7). Serial AF samples were collected for 120 h. Inflammatory responses were characterized by quantitative polymerase chain reaction (qPCR), histology, fluorescent immunohistochemistry, enzyme-linked inmmunosorbent assay (ELISA), fluorescent western blotting and blood chemistry analysis. Results: LPS-treated animals had endotoxin and AF monocyte chemoattractant protein (MCP)-1 concentrations that were significantly higher at 24 hours (immediately prior to rytvela administration) relative to values from Saline Group animals. Following rytvela administration, the average MCP-1 concentrations in the AF were significantly lower in the LPS + rytvela Group relative to in the LPS Group. In delivery samples, the expression of IL-1β in fetal skin was significantly lower in the LPS + rytvela Group compared to the LPS Group. Conclusion: A single dose of rytvela was associated with partial, modest inhibition in the expression of a panel of cytokines/chemokines in fetal tissues undergoing an active inflammatory response.


  • Open Access

    Corrigendum: Chronic Intra-Uterine Ureaplasma parvum Infection Induces Injury of the Enteric Nervous System in Ovine Fetuses

    by Cathelijne Heymans, Ilse H. de Lange, Matthias C. Hütten, Kaatje Lenaerts, Nadine J. E. de Ruijter, Lilian C. G. A. Kessels, Glenn Rademakers, Veerle Melotte, Werend Boesmans, Masatoshi Saito, et al.

    Corrigendum: Chronic Intra-Uterine Ureaplasma parvum Infection Induces Injury of the Enteric Nervous System in Ovine Fetuses


  • Open Access

    Dose of budesonide with surfactant affects lung and systemic inflammation after normal and injurious ventilation in preterm lambs

    by Noah H. Hillman, Leenah Abugisisa, Emily Royse, Erin Fee, Matthew W. Kemp, Boris W. Kramer, Augusto F. Schmidt, Fabrizio Salomone, Michael W. Clarke, Gabrielle C. Musk, et al.

    Background The addition of budesonide (Bud) 0.25 mg/kg to surfactant decreased the lung and systemic responses to mechanical ventilation in preterm sheep and the rates and severity of bronchopulmonary dysplasia (BPD) in preterm infants. We hypothesized that lower budesonide concentrations in surfactant will decrease injury while decreasing systemic corticosteroid exposure. Methods Preterm lambs received either (1) protective tidal volume (VT) ventilation with surfactant from birth or (2) injurious VT ventilation for 15 min and then surfactant treatment. Lambs were further assigned to surfactant mixed with (i) Saline, (ii) Bud 0.25 mg/kg, (iii) Bud 0.1 mg/kg, or (iv) Bud 0.04 mg/kg. All lambs were then ventilated with protective VT for 6 h. Results Plasma Bud levels were proportional to the dose received and decreased throughout ventilation. In both protective and injurious VT ventilation, <4% of Bud remained in the lung at 6 h. Some of the improvements in physiology and markers of injury with Bud 0.25 mg/kg were also found with 0.1 mg/kg, whereas 0.04 mg/kg had only minimal effects. Conclusions Lower doses of Bud were less effective at decreasing lung and systemic inflammation from mechanical ventilation. The plasma Bud levels were proportional to dose given and the majority left the lung.


  • The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation

    by Matthew W. Kemp, Masatoshi Saito, Augusto F. Schmidt, Haruo Usuda, Shimpei Watanabe, Shinichi Sato, Takushi Hanita, Yusaku Kumagai, Tsukasa Takahashi, Gabrielle C. Musk, et al.


  • Peer relationships and the biomedical doctorate: a key component of the contemporary learning environment

    by Matthew W. Kemp, Timothy J. Molloy, Marina Pajic, Elaine Chapman

    Little attention has been paid to the scholarship of doctoral education in the biomedical sciences, hindering the formulation of research-informed improvements to this important area of higher education. We present an analysis of interview data from Australian PhD students and suggest that relationships between students and their ‘non-supervisor’ peers are critical to student learning.